JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WENDEL, W. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by WENDEL, W. B.
Journal of Pharmacology And Experimental Therapeutics, Vol. 54, Issue 3, 283-298, 1935
Copyright © 1935 by American Society for Pharmacology and Experimental Therapeutics


METHYLENE BLUE, METHEMOGLOBIN, AND CYANIDE POISONING

WILLIAM B. WENDEL 1

1 From the Department of Chemistry, University of Tennessee, College of Medicine, Memphis

Methemoglobin does not accumulate in significant quantities in the blood of dogs after intravenous injection of clinically recommended quantities of methylene blue. This fact, however, should not bring into question the proposed methemoglobin explanation of the dye's action in cyanide poisoning. The failure of methemoglobin to accumulate is explicable on the basis of the known behavior of the reactions involved, namely, the reduction of the formed methemoglobin by leuco-methylene blue and the enzyme systems present in the erythrocytes, and the rapid disappearance of the injected dye from the blood. In vivo formation of methemoglobin is readily demonstrable after administration of both cyanide and methylene blue because of the stability of the cyanmethemoglobin which is formed. Considerably more than half of 2 m.l.d. of subcutaneously administered cyanide is demonstrably bound in the circulating erythrocytes of dogs injected with methylene blue immediately before administration of the cyanide. When the dye is injected continuously throughout the period of cyanide absorption a still greater fraction of the cyanide is bound in the blood. The principal action of methylene blue in counteracting the toxic effects of cyanide appears to depend, therefore, upon methemoglobin formation. In the absence of experimental demonstration that methylene blue can replace the cyanide sensitive catalysts which are concerned with vital processes the methemoglobin explanation appears to be all that is required.

Submitted on March 18, 1935







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1935 by the American Society for Pharmacology and Experimental Therapeutics.